annual CFI:
$4.88M+$10.89M(+181.33%)Summary
- As of today (September 16, 2025), XERS annual cash flow from investing activities is $4.88 million, with the most recent change of +$10.89 million (+181.33%) on December 31, 2024.
- During the last 3 years, XERS annual CFI has fallen by -$93.08 million (-95.02%).
- XERS annual CFI is now -95.02% below its all-time high of $97.96 million, reached on December 31, 2021.
Performance
XERS Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$279.00K-$266.00K(-2046.15%)Summary
- As of today (September 16, 2025), XERS quarterly cash flow from investing activities is -$279.00 thousand, with the most recent change of -$266.00 thousand (-2046.15%) on June 30, 2025.
- Over the past year, XERS quarterly CFI has dropped by -$4.88 million (-106.06%).
- XERS quarterly CFI is now -100.76% below its all-time high of $36.60 million, reached on December 31, 2021.
Performance
XERS quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$19.64M-$4.88M(-19.91%)Summary
- As of today (September 16, 2025), XERS TTM cash flow from investing activities is $19.64 million, with the most recent change of -$4.88 million (-19.91%) on June 30, 2025.
- Over the past year, XERS TTM CFI has increased by +$5.16 million (+35.66%).
- XERS TTM CFI is now -79.95% below its all-time high of $97.96 million, reached on December 31, 2021.
Performance
XERS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
XERS Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +181.3% | -106.1% | +35.7% |
| 3 y3 years | -95.0% | -102.3% | -73.3% |
| 5 y5 years | +304.9% | -101.6% | +35.6% |
XERS Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -95.0% | +181.3% | -101.9% | +99.4% | -73.3% | +199.9% |
| 5 y | 5-year | -95.0% | +117.8% | -100.8% | +99.5% | -80.0% | +144.9% |
| alltime | all time | -95.0% | +107.2% | -100.8% | +99.5% | -80.0% | +122.7% |
XERS Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$279.00K(+2046.2%) | $19.64M(-19.9%) |
| Mar 2025 | - | -$13.00K(-100.1%) | $24.52M(+402.2%) |
| Dec 2024 | $4.88M(-181.3%) | $10.02M(+1.0%) | $4.88M(-49.8%) |
| Sep 2024 | - | $9.91M(+115.4%) | $9.73M(-32.8%) |
| Jun 2024 | - | $4.60M(-123.4%) | $14.48M(-21.0%) |
| Mar 2024 | - | -$19.65M(-232.2%) | $18.32M(-405.2%) |
| Dec 2023 | -$6.00M(-117.4%) | $14.87M(+1.5%) | -$6.00M(-48.7%) |
| Sep 2023 | - | $14.65M(+73.4%) | -$11.70M(-40.4%) |
| Jun 2023 | - | $8.45M(-119.2%) | -$19.65M(+21.0%) |
| Mar 2023 | - | -$43.98M(-579.7%) | -$16.23M(-147.1%) |
| Dec 2022 | $34.46M(-64.8%) | $9.17M(+36.7%) | $34.46M(-44.3%) |
| Sep 2022 | - | $6.71M(-43.5%) | $61.90M(-16.0%) |
| Jun 2022 | - | $11.87M(+76.7%) | $73.69M(-6.0%) |
| Mar 2022 | - | $6.72M(-81.7%) | $78.38M(-20.0%) |
| Dec 2021 | $97.96M | $36.60M(+97.8%) | $97.96M(+42.8%) |
| Sep 2021 | - | $18.50M(+11.8%) | $68.61M(-749.2%) |
| Jun 2021 | - | $16.56M(-37.1%) | -$10.57M(+8.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $26.30M(+262.8%) | -$9.78M(-64.3%) |
| Dec 2020 | -$27.41M(+1050.0%) | $7.25M(-111.9%) | -$27.41M(-37.3%) |
| Sep 2020 | - | -$60.67M(-449.8%) | -$43.70M(-401.7%) |
| Jun 2020 | - | $17.34M(+99.9%) | $14.48M(-42.1%) |
| Mar 2020 | - | $8.68M(-196.0%) | $25.02M(-1149.9%) |
| Dec 2019 | -$2.38M(-96.5%) | -$9.04M(+262.2%) | -$2.38M(-53.0%) |
| Sep 2019 | - | -$2.50M(-109.0%) | -$5.07M(-91.4%) |
| Jun 2019 | - | $27.88M(-248.9%) | -$58.62M(-32.4%) |
| Mar 2019 | - | -$18.73M(+59.7%) | -$86.65M(+26.9%) |
| Dec 2018 | -$68.26M(+9651.6%) | -$11.72M(-79.1%) | -$68.26M(+20.2%) |
| Sep 2018 | - | -$56.05M(>+9900.0%) | -$56.77M(+7469.9%) |
| Jun 2018 | - | -$156.00K(-53.2%) | -$750.00K(+26.3%) |
| Mar 2018 | - | -$333.00K(+41.1%) | -$594.00K(-1.5%) |
| Dec 2017 | -$700.00K(+1900.0%) | -$236.00K(+844.0%) | -$603.00K(+64.3%) |
| Sep 2017 | - | -$25.00K(-92.7%) | -$367.00K(+7.3%) |
| Mar 2017 | - | -$342.00K | -$342.00K |
| Dec 2016 | -$35.00K | - | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual CFI year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly CFI year-on-year change?
- What is Xeris Biopharma Holdings, Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. TTM CFI year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual cash flow from investing activities?
The current annual CFI of XERS is $4.88M
What is the all time high annual CFI for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual cash flow from investing activities is $97.96M
What is Xeris Biopharma Holdings, Inc. annual CFI year-on-year change?
Over the past year, XERS annual cash flow from investing activities has changed by +$10.89M (+181.33%)
What is Xeris Biopharma Holdings, Inc. quarterly cash flow from investing activities?
The current quarterly CFI of XERS is -$279.00K
What is the all time high quarterly CFI for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly cash flow from investing activities is $36.60M
What is Xeris Biopharma Holdings, Inc. quarterly CFI year-on-year change?
Over the past year, XERS quarterly cash flow from investing activities has changed by -$4.88M (-106.06%)
What is Xeris Biopharma Holdings, Inc. TTM cash flow from investing activities?
The current TTM CFI of XERS is $19.64M
What is the all time high TTM CFI for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high TTM cash flow from investing activities is $97.96M
What is Xeris Biopharma Holdings, Inc. TTM CFI year-on-year change?
Over the past year, XERS TTM cash flow from investing activities has changed by +$5.16M (+35.66%)